C-type natriuretic peptide and collagen X marker are aberrant in skeletal dysplasias. [PDF]
Carroll RS +13 more
europepmc +1 more source
C-type natriuretic peptide mitigates apoptosis in ovarian granulosa cells through the cGMP pathway independent of PKG signaling. [PDF]
Wei Y +6 more
europepmc +1 more source
Phase 1 safety, tolerability, pharmacokinetics and pharmacodynamics results of a long-acting C-type natriuretic peptide prodrug, TransCon CNP. [PDF]
Breinholt VM +6 more
europepmc +1 more source
Hypertrichosis associated with the use of C-type natriuretic peptide analogue: a case report. [PDF]
Clinton JL +3 more
europepmc +1 more source
C-type natriuretic peptide facilitates autonomic Ca2+ entry in growth plate chondrocytes for stimulating bone growth. [PDF]
Miyazaki Y +17 more
europepmc +1 more source
Evidence of feedback regulation of C-type natriuretic peptide during Vosoritide therapy in Achondroplasia. [PDF]
Prickett TCR +10 more
europepmc +1 more source
Endothelium- and Fibroblast-Derived C-Type Natriuretic Peptide Prevents the Development and Progression of Aortic Aneurysm. [PDF]
Aubdool AA +17 more
europepmc +1 more source
Prognostic Value of Urinary and Plasma C-Type Natriuretic Peptide in Acute Decompensated Heart Failure. [PDF]
Ma X +10 more
europepmc +1 more source
Optimizing C-Type Natriuretic Peptide and Receptor Expression Analysis with Droplet Digitalâ„¢ PCR: Advancing Biomarker Discovery for Brugada Syndrome? [PDF]
Cabiati M +13 more
europepmc +1 more source
C-type natriuretic peptide attenuates enhanced glycolysis and de novo pyrimidine synthesis in pericytes of patients with pulmonary arterial hypertension. [PDF]
Noh M +12 more
europepmc +1 more source

